우시앱텍 WUXI APPTECH 603259

기본정보

해외거래소국가코드	CHN	거래소구분코드	SHC
업종구분명	Bio Therapeutic Drugs	종업원총수	21,744명
유통주식수	1,150,253,338.00	발행주식수(자사주제외)	2,311,577,143.00
대표이사명	Ge Li	국제전화번호	20663091
회사주소	No. 288 Fute Middle Road Waigaoqiao Free Trade Zone SHANGHAI SHA 200131 China
홈페이지	http://www.wuxiapptec.com.cn/
사업개요	WuXi AppTec Co., Ltd. is a China-based investment holding company principally engaged in the provision of new drug research and development (R&D), production and supporting services, as well as related technology platform services. The Company is mainly engaged in the discovery, development and production of small molecule drugs, cell therapies and gene therapies, as well as providing testing services for medical devices. The Company mainly conducts its businesses through four segments, including China-based Laboratory Services segment, Contract Manufacturing organization/contract development and manufacturing organization services (CMO/CDMO services) segment, US-based Laboratory Services segment and Clinical Research segment. WuXi AppTec Co., Ltd.는 주로 신약 연구 개발 (R & D), 생산 및 지원 서비스, 관련 기술 플랫폼 서비스 제공에 종사하는 중국 기반 투자 지주 회사입니다. 이 회사는 주로 소분자 약물, 세포 요법 및 유전자 요법의 발견, 개발 및 생산에 관여하고 의료 기기에 대한 테스트 서비스를 제공합니다. 회사는 주로 중국 기반 실험실 서비스 부문, 계약 제조 조직 / 계약 개발 및 제조 조직 서비스 (CMO / CDMO 서비스) 부문, 미국 기반 실험실 서비스 부문 및 임상 연구 부문을 포함한 4 가지 부문을 통해 비즈니스를 수행합니다.

 

재무요약

[단위: 백만, CNY ]

매출액(최근결산)	13,290.25	주당매출액(최근결산)	5.55
매출액변동률	15.09	EBITD	2,543.82
EBITD이익률	37.83	세전이익	2,249.48
당기순이익	1,771.11	부채/자본	0
총자본이익률(최근결산)	9.80	총자산이익률(최근결산)	6.68
주당배당금	0.24	주당현금흐름(최근결산)	0
EPS(최근결산)	0	EPS등락률(전년동기대비)	0
PBR(최근결산)	0	PER(최근결산)	140.79
PSR(최근결산)	20.15	PCR(최근결산)	0
배당성향	31.42	배당이익률	0.21